BioCardia, Inc. (BCDA): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2021-12-31
$1.06M2015-12-31: $1.06M2016-12-31: $746.0K2017-12-31: $690.0K2018-12-31: $517.0K2019-12-31: $358.0K2020-12-31: $4.0K2021-12-31: $0$0
2015-12-31 Cost of Revenue (USD) 2021-12-31
Period endedCost of RevenueChange YoYSource filing
2021-12-31$0-100.0%2022-03-29, From 2021-01-01
2020-12-31$4.0K-98.9%2022-03-29, From 2020-01-01
2019-12-31$358.0K-30.8%2021-03-30, From 2019-01-01
2018-12-31$517.0K-25.1%2020-04-09, From 2018-01-01
2017-12-31$690.0K-7.5%2020-04-09, From 2017-01-01
2016-12-31$746.0K-29.7%2019-04-02, From 2016-01-01
2015-12-31$1.06Mn/a2018-03-16, From 2015-01-01